Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study
Abstract Background Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide despite correct antibiotic use. Corticosteroids have long been evaluated as a treatment option, but heterogeneous effects on survival have precluded their widespread implementation. We aime...
Main Authors: | A. Ceccato, A. Russo, E. Barbeta, P. Oscanoa, G. Tiseo, A. Gabarrus, P. Di Giannatale, S. Nogas, C. Cilloniz, F. Menichetti, M. Ferrer, M. Niederman, M. Falcone, A. Torres |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-12-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13054-021-03840-x |
Similar Items
-
Efficacy of corticosteroids as an adjunctive therapy in the treatment of community-acquired pneumonia: a systematic review and meta-analysis
by: Lydia Mukanhaire, et al.
Published: (2023-01-01) -
New aspects in the management of pneumonia
by: Elena Prina, et al.
Published: (2016-10-01) -
Adjuvant Inhaled Corticosteroids in Community-Acquired Pneumonia: A Review Article
by: Faeq R. Kukhon, et al.
Published: (2021-05-01) -
Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis
by: Masaru Ejima, et al.
Published: (2021-07-01) -
Effect of corticosteroid therapy in the early phase of acute respiratory distress syndrome: a propensity-matched cohort study
by: Moon Seong Baek, et al.
Published: (2021-01-01)